Lumos Diagnostics Holdings Limited (ASX:LDX)
Australia · Delayed Price · Currency is AUD 0.1000
0.00 (0.00%)
Aug 28, 2026, 4:10 PM AEST
ASX:LDX Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 13.19 | 12.4 | 11.13 | 10.54 | 11.63 | |
Revenue Growth | 6.39% | 11.40% | 5.66% | -9.41% | -38.31% |
Cost of Revenue | 5.32 | 4.72 | 4.57 | 5.21 | 9.76 |
Gross Profit | 7.88 | 7.68 | 6.56 | 5.32 | 1.88 |
Selling, General & Admin | 19.05 | 13.11 | 11.5 | 11.64 | 21.89 |
Research & Development | 0.42 | 0.11 | 0.07 | 0.25 | 1.33 |
Operating Expenses | 22.01 | 15.75 | 14.22 | 15.56 | 28.78 |
Operating Income | -14.13 | -8.07 | -7.66 | -10.23 | -26.9 |
Interest Expense | -2.05 | -0.56 | -1.02 | -2.39 | -0.57 |
Interest & Investment Income | - | 0.06 | 0.05 | 0.02 | 0 |
Other Non Operating Income (Expenses) | 4.91 | 1.44 | -0 | 2.04 | -0.02 |
EBT Excluding Unusual Items | -11.27 | -7.13 | -8.64 | -10.56 | -27.5 |
Merger & Restructuring Charges | - | - | - | - | -1.68 |
Impairment of Goodwill | - | - | - | - | -1.02 |
Gain (Loss) on Sale of Investments | - | - | - | - | -0.2 |
Gain (Loss) on Sale of Assets | - | -0.05 | 0.04 | 1.59 | 0.02 |
Asset Writedown | 6.32 | - | - | - | -15.35 |
Pretax Income | -4.95 | -7.18 | -8.59 | -8.97 | -45.72 |
Net Income | -4.95 | -7.18 | -8.59 | -8.97 | -45.72 |
Net Income to Common | -4.95 | -7.18 | -8.59 | -8.97 | -45.72 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 812 | 680 | 463 | 235 | 152 |
Shares Outstanding (Diluted) | 812 | 680 | 463 | 235 | 152 |
Shares Change | 19.35% | 46.85% | 97.23% | 54.17% | - |
EPS (Basic) | -0.01 | -0.01 | -0.02 | -0.04 | -0.30 |
EPS (Diluted) | -0.01 | -0.01 | -0.02 | -0.04 | -0.30 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -1.52 | -9.39 | 0.89 | -9.76 | -20.56 |
Free Cash Flow Per Share | -0.00 | -0.01 | 0.00 | -0.04 | -0.14 |
Gross Margin | 59.70% | 61.93% | 58.96% | 50.54% | 16.12% |
Operating Margin | -107.11% | -65.07% | -68.79% | -97.13% | -231.32% |
Profit Margin | -37.54% | -57.93% | -77.19% | -85.15% | -393.16% |
Free Cash Flow Margin | -11.55% | -75.70% | 8.03% | -92.67% | -176.78% |
EBITDA | -11.58 | -7.46 | -6.97 | -9.07 | -25.67 |
EBITDA Margin | -87.81% | -60.19% | -62.64% | -86.10% | -220.70% |
D&A For EBITDA | 2.55 | 0.61 | 0.69 | 1.16 | 1.24 |
EBIT | -14.13 | -8.07 | -7.66 | -10.23 | -26.9 |
EBIT Margin | -107.11% | -65.07% | -68.79% | -97.13% | -231.32% |